NanoVibronix, Inc.
Index- P/E- EPS (ttm)-0.40 Insider Own0.30% Shs Outstand28.00M Perf Week3.22%
Market Cap18.99M Forward P/E- EPS next Y- Insider Trans- Shs Float27.26M Perf Month-1.01%
Income-10.50M PEG- EPS next Q- Inst Own6.50% Short Float1.50% Perf Quarter28.65%
Sales1.90M P/S10.00 EPS this Y-35.20% Inst Trans-0.57% Short Ratio3.20 Perf Half Y-20.27%
Book/sh0.19 P/B3.72 EPS next Y- ROA-128.10% Target Price- Perf Year-75.52%
Cash/sh0.22 P/C3.17 EPS next 5Y- ROE-171.80% 52W Range0.48 - 4.19 Perf YTD-31.96%
Dividend- P/FCF- EPS past 5Y1.70% ROI-90.70% 52W High-83.25% Beta0.63
Dividend %- Quick Ratio3.50 Sales past 5Y49.20% Gross Margin42.90% 52W Low45.87% ATR0.04
Employees12 Current Ratio3.70 Sales Q/Q200.00% Oper. Margin- RSI (14)54.55 Volatility6.75% 6.01%
OptionableNo Debt/Eq0.00 EPS Q/Q80.10% Profit Margin- Rel Volume1.08 Prev Close0.71
ShortableYes LT Debt/Eq0.00 Earnings- Payout- Avg Volume127.40K Price0.70
Recom2.00 SMA202.41% SMA504.46% SMA200-19.49% Volume69,280 Change-0.82%
Jul-25-22 08:30AM  
Jul-12-22 08:30AM  
Jun-29-22 08:30AM  
May-17-22 08:30AM  
May-04-22 08:30AM  
Apr-25-22 08:30AM  
Apr-05-22 08:30AM  
Mar-30-22 11:16AM  
Feb-14-22 01:45PM  
Feb-07-22 08:30AM  
Jan-31-22 04:15PM  
Jan-24-22 08:30AM  
Jan-19-22 08:30AM  
Jan-13-22 08:30AM  
Jan-07-22 01:02PM  
Jan-06-22 08:30AM  
Jan-05-22 08:30AM  
Dec-21-21 03:15PM  
Dec-15-21 09:01AM  
Dec-08-21 11:10AM  
Dec-07-21 09:00AM  
Dec-02-21 05:30AM  
Nov-16-21 08:30AM  
Oct-28-21 09:28AM  
Oct-11-21 10:40AM  
Sep-29-21 10:14AM  
Sep-14-21 12:12PM  
Aug-17-21 02:32PM  
Aug-16-21 04:05PM  
Aug-11-21 08:30AM  
Aug-05-21 08:52AM  
Jul-29-21 09:00AM  
Jul-26-21 10:47AM  
Jul-23-21 03:03PM  
Jul-22-21 08:15AM  
Jun-03-21 08:30AM  
Apr-27-21 11:17AM  
Apr-26-21 09:00AM  
Apr-19-21 09:50AM  
Apr-14-21 12:57PM  
Mar-31-21 06:50PM  
Mar-02-21 08:30AM  
Feb-10-21 08:00AM  
Feb-03-21 08:00AM  
Jan-22-21 11:12AM  
Jan-19-21 08:00AM  
Dec-11-20 08:00AM  
Dec-08-20 08:00AM  
Dec-07-20 05:10PM  
Dec-02-20 01:01PM  
Nov-16-20 06:12PM  
Oct-16-20 08:30AM  
Oct-08-20 09:00AM  
Sep-29-20 08:49AM  
Sep-22-20 08:36PM  
Aug-27-20 03:42PM  
Aug-24-20 10:58PM  
Aug-13-20 08:30AM  
Jul-07-20 08:00AM  
Jun-16-20 08:00AM  
Jun-01-20 08:00AM  
Apr-02-20 11:06AM  
Apr-01-20 08:00AM  
NanoVibronix, Inc., through its subsidiary, NanoVibronix Ltd., focuses on the manufacture and sale of noninvasive biological response-activating devices that target biofilm prevention, wound healing, and pain therapy. Its principal products include UroShield, an ultrasound-based product to prevent bacterial colonization and biofilm in urinary catheters, enhance antibiotic efficacy, and decrease pain and discomfort associated with urinary catheter use; PainShield, a patch-based therapeutic ultrasound technology to treat pain, muscle spasm, and joint contractures; and WoundShield, a patch-based therapeutic ultrasound device, which facilitates tissue regeneration and wound healing. The company sells its products directly to patients, as well as through distributor agreements in the United States, Israel, Europe, India, and internationally. NanoVibronix, Inc. was incorporated in 2003 and is based in Elmsford, New York.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
FASHEK CHRISTOPHER MDirectorJun 15Buy0.6040,00023,82875,000Jun 17 04:17 PM
BROWN STEPHEN RUSSELLChief Financial OfficerJun 14Buy0.574,0002,2964,000Jun 14 04:15 PM
Cassirer AuroraDirectorJun 01Buy0.692,0001,3802,000Jun 02 06:10 AM